Skip to main content

Animations

MJFF Publications

4921 - 4930 of 9188 Results
Title
Year
  • Year
  • 2016
  • 2017
  • 2017
  • 2022
  • 2017
  • 2013
  • 2014
  • 2012
  • 2021
  • 2019
  • Summary Details
    OPEN
    Title: The IgLON Family Member Negr1 Promotes Neuronal Arborization Acting as Soluble Factor via FGFR2
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2015.00089
    Citation Count: 62
  • Summary Details
    OPEN
    Title: Functional connectivity disruptions correlate with cognitive phenotypes in Parkinson's disease
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2017.03.002
    Citation Count: 110
  • DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.
    2017
    Summary Details
    RESTRICTED
    Title: DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.11.046
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Cholinergic brain network deficits associated with vestibular sensory conflict deficits in Parkinson’s disease: correlation with postural and gait deficits
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00702-022-02523-3
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12478
    Citation Count: 88
  • Summary Details
    OPEN
    Title: 5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2013.08.014
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Concomitant pathologies among a spectrum of parkinsonian disorders
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.02.012
    Citation Count: 164
  • Summary Details
    OPEN
    Title: Alzheimer's disease: Pathogenesis and prevention
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2012.01.011
    Citation Count: 103
  • Summary Details
    OPEN
    Title: Genetic Evidence Supporting a Causal Role of Depression in Alzheimer’s Disease
    Journal Name: Biological Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.biopsych.2021.11.025
    Citation Count: 68
  • Summary Details
    OPEN
    Title: mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cells
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.038596
    Citation Count: 74
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.